# Evaluation of the Epilepsy-related Quality of Life, Seizure-related Accidents and Validation of the Mjn-SERAS Solution in the Normalised Patient Environment with Real-World Data

> **NCT05845255** · — · RECRUITING · sponsor: **MJN Neuroserveis, S.L** · enrollment: 130 (estimated)

## Conditions studied

- Quality of Life
- Epilepsy (treatment Refractory)

## Interventions

- **DEVICE:** mjn-SERAS

## Key facts

- **NCT ID:** NCT05845255
- **Lead sponsor:** MJN Neuroserveis, S.L
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-01
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2024-10-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05845255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05845255, "Evaluation of the Epilepsy-related Quality of Life, Seizure-related Accidents and Validation of the Mjn-SERAS Solution in the Normalised Patient Environment with Real-World Data". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05845255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*